CG
BNTX icon

Cutler Group’s BioNTech BNTX Stock Holding History

Cutler Group’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,000
Closed -$95K – 3834
2022
Q4 		$95K Sell
5,000
-1,900
-28% -$292K 0.01% 1183
2022
Q3 		$178K Sell
6,900
-800
-10% -$122K 0.01% 1024
2022
Q2 		$244K Sell
7,700
-47,300
-86% -$7.23M 0.02% 895
2022
Q1 		$3.08M Buy
55,000
+6,400
+13% +$1.08M 0.16% 128
2021
Q4 		$2.08M Buy
48,600
+40,000
+465% +$11M 0.09% 243
2021
Q3 		$5K Hold
8,600
– – ﹤0.01% 4413
2021
Q2 		$24K Sell
8,600
-1,500
-15% -$283K ﹤0.01% 3128
2021
Q1 		$165K Sell
10,100
-4,500
-31% -$478K 0.01% 1404
2020
Q4 		$375K Buy
14,600
+3,800
+35% +$373K 0.02% 765
2020
Q3 		$47K Sell
10,800
-5,100
-32% -$366K ﹤0.01% 1836
2020
Q2 		$67K Buy
+15,900
New +$794K ﹤0.01% 1548

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Cutler Group's BNTX Position: Q1 2023 in Review

Cutler Group sold out of BioNTech (BNTX) in Q1 2023, closing a stake of 3,000 shares — an estimated $412K sold.

Cutler Group first reported a position in BNTX in Q3 2020 and held it in 10 quarters. The position peaked at $5.63M in Q1 2022. 282 funds tracked by Wall St. Rank hold BNTX as of Q1 2023.

  • Cutler Group reported no remaining BioNTech position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 3,000 BioNTech shares in Q1 2023, an estimated $412K.
  • Cutler Group first reported a position in BioNTech in Q3 2020 and held it in 10 quarters.
  • Cutler Group's BioNTech position peaked at $5.63M in Q1 2022.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.